Alisa Lee Sherick MD
University of Colorado Denver
Targeting MerTK as an immunotherapeutic strategy in pediatric acute myeloid leukemia
Mirian Rosenberg, PhD
Hebrew University of Jerusalem/ The Children's Hospital of Philadelphia
Autoantigen discovery and immune profiling of Opsoclonus Myoclonus Syndrome
Shahrzad Bahrampour , Ph.D
The Hospital for Sick Children, Toronto
Unconventional role of volume-regulated anion channel in pediatric brain tumor
Funded by #ColbyStrong
Aasef G. Shaikh MD,PhD
Functional Electrical Stimulation Institute
Membranes and Models - Towards Targeted Therapy of Opsoclonus
Funded in partnership with The Viswanatha Family + Friends
Patricia Denise B. Tiburcio, PhD
University of Texas, Southwestern
Targeting Proteasome and mTOR pathways in Actinomycin-Resistant Wilms Tumors
Funded by Funded by Gentleman Toker In Honor of Michelle Laderman
Delfim Duarte, MD PhD
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia
Amy Erbe-Gurel, PhD
University of Wisconsin
Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities
Dung-Fang Lee, PhD
The University of Texas Health Science Center
The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma
Vicki Huff, PhD
University of Texas M.D. Anderson Cancer Center
Assessment of a cancer preventive agent for Wilms tumor
Thais Armangue, MD, PhD
Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain
Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling
Grant Funded in Partnership with The Viswanatha Family + Friends
Julien Fleurence PhD, PharmD
Baylor College of Medicine
T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers
Lai Man (Natalie) Wu , PhD
Cincinnati Children’s Hospital Medical Center
Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy
Supported in part by Hanna's Hoops 4 Healing
Alexandra Stevens, MD, PhD
Baylor College of Medicine
Predicting Atovaquone-Induced Apoptosis in Pediatric AML
Grant Rowe, MD PhD
Children’s Hospital Boston
Targeting leukemia stem cells in infant B-lymphoblastic leukemia
This grant is funded by Change a Life Foundation
Laura Perin, PhD
Children's Hospital Los Angeles
Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?
Surinder Kumar, PhD
University of Michigan
The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma
This grant is funded by Peloton Magazine
Kathryn Lemberg, md, phd
Johns Hopkins University - School of Medicine
Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors
W. Clay Gustafson, md, phd
University of California San Francisco
Drugging the Aurora Kinase A Interactome in Neuroblastoma